ARENA Foundation for Medical Research Award: John Ultmann Award for Major Contribution to Lymphoma Research

Award Talk: Advancing Toward Cure in Follicular Lymphoma: Novel Therapies and Long-Term Outcomes Follicular lymphoma management is rapidly evolving as novel immunotherapies deliver unprecedented response durability and improved outcomes across multiple treatment settings. In this CME activity, Dr. Thomas Witzig examines emerging evidence supporting a shift toward cure-oriented treatment strategies, including long-term follow-up demonstrating sustained remissions with CAR T-cell therapy beyond 5 years, with newer cellular and immune-based approaches, and significant progression-free survival improvements with bispecific antibody-based combinations. The session will also explore outcomes in high-risk populations, including POD24 disease, evolving treatment sequencing paradigms, and the implications of long-term efficacy and safety data for clinical practice.